Retractable Technologies (NYSE:RVP) Earns Hold Rating from Analysts at StockNews.com

Investment analysts at StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVPGet Free Report) in a research report issued on Sunday. The brokerage set a “hold” rating on the stock.

Retractable Technologies Stock Performance

NYSE RVP opened at $0.82 on Friday. The company has a quick ratio of 5.92, a current ratio of 8.57 and a debt-to-equity ratio of 0.01. The company has a market capitalization of $24.55 million, a P/E ratio of -1.52 and a beta of 1.96. Retractable Technologies has a 12-month low of $0.56 and a 12-month high of $1.33. The firm has a 50-day moving average price of $0.76 and a two-hundred day moving average price of $0.77.

Institutional Trading of Retractable Technologies

A number of institutional investors have recently bought and sold shares of RVP. PFG Investments LLC bought a new stake in Retractable Technologies in the 3rd quarter valued at about $27,000. Wealthfront Advisers LLC bought a new stake in shares of Retractable Technologies during the 4th quarter worth approximately $1,748,000. Finally, Renaissance Technologies LLC lifted its holdings in shares of Retractable Technologies by 9.4% during the 4th quarter. Renaissance Technologies LLC now owns 361,253 shares of the company’s stock worth $249,000 after acquiring an additional 31,140 shares during the period. Institutional investors own 7.58% of the company’s stock.

Retractable Technologies Company Profile

(Get Free Report)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

Featured Articles

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.